Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

274results about How to "Maintain level" patented technology

Objective optical system

An objective optical system includes a first group having positive refractive power and a piano-convex lens with the convex surface facing the image side; a second group having positive refractive power and a lens whose extreme-object-side lens surface is a convex surface facing the object side; a third group having negative refractive power and a lens whose extreme-image-side lens surface is a concave surface facing the image side; a fourth group having positive refractive power and a lens disposed on the extreme object side, whose image-side lens surface is a convex surface facing the image side and a lens disposed on the extreme image side, whose object-side lens surface is a convex surface facing the object side; and a fifth group having positive refractive power and a combined lens formed by joining a convex lens and a concave lens, the joined surface having negative refractive power.
Owner:EVIDENT CORP

Mobile station and communication control method

When an application is activated, a mobile station 10 detects external devices 20, 30, 40 as candidates for a BLUETOOTH connection out of external devices existing in the surrounding area, and presents a list of the devices to a user. When the user selects from the list an external device 20 with which a connection is to be attempted to make, a link is established by a connection procedure according to a security level described in an ADF of the application. Namely, when “high” is described as the security level, an authentication process and an encryption process requiring input of a PIN are executed prior to the establishment of the link. On the other hand, when “low” is described as the security level, a link is established without executing these processes.
Owner:NTT DOCOMO INC

Computer resource distribution method based on prediction

A resource distribution method capable of lending surplus resources among a plurality of services and reducing the maintenance cost of the surplus resources is provided. Computer resources in the standby system have a dead standby state in which at least an application is not installed. A plurality of services or a plurality of users share the computer resources in the standby system. As a result, improvement of the utilization factor of idle computer resources and server integration are implemented, and the cost required to maintain the computer resources is reduced. Furthermore, load prediction is conducted as regards individual services by using past operation history. Idle computer resources secured from services having surplus and maintained are thrown in according to a result of the prediction.
Owner:HITACHI LTD

Controlled release formulations using intelligent polymers

InactiveUS6893661B1Promote absorptionMaintenance of therapeutically effective blood levelPowder deliveryOrganic active ingredientsSmart polymerWater contact
An extended release dosage composition of pharmaceutically active substances that have a water contact angle (θ) such that cos θ is between +0.9848 and −0.9848 presented as a matrix tablet containing the said pharmaceutically active substances, with / without suitable pharmaceutical excipients in intimate mixture with two groups of intelligent polymers having opposing wettability characteristics, one demonstrating a stronger tendency towards hydrophobicity and the other a stronger tendency towards hydrophilicity, the polymer combination being between the ratios of 1:50 and 50:1 amounts effective to control the release of said pharmaceutically active substances in a mathematically predictable manner, wherein the polymer demonstrating a stronger tendency towards hydrophobicity is not less than 5% wt / wt and preferably between 5-70% wt / wt of the final formulation composition. The intelligent polymers being ethylcellulose (EC) as a more strongly hydrophobic and hydroxyethylcellulose (HEC) and / or hydroxypropyl methylcellulose (HPMC) as more strongly hydrophilic (the ratio of HEC to HPMC being between 1:100 and 100:1). The matrix tablet is optionally coated with an enteric coat, 0-5%-15% wt / wt to prevent the initial burst effect seen in such systems and to impart gastrointestinal tract (GIT) “stealth” characteristics especially in the presence of food.
Owner:VALEANT INT BERMUDA

Four position gate latch assembly

A four position gate latch (20) that is used to fasten and lock a gate. The gate latch includes a self fastening gravity gate latch (22) that is fastened to one face of the gate. A gate latch bracket (28) is fastened to the gate on an opposed face, mating with said gate latch. A latch striker bar slideably extends from the bracket such that the striker bar interfaces with the gate latch and links the gate portions together. A locking bolt (60) slideably extends though the bracket, allowing it to interface with the gate latch and provide positive locking capabilities. The gate latch is capable of being placed in a self fastening gravity gate latch conventional position, a locked position with the locking bolt penetrating a padlock hole, an unlatched position that permits the gate to swing inward on the gate latch side without interference, and a free-swinging position that permits the gate to pivot in both directions.
Owner:RAOULT PHILIPPE P

Adaptive gain control system

An automatic gain control system maintains desired signal content level, such as voice, in an output signal. The system includes automatic gain control over an input signal, and compensates the output signal based on input signal content. When the input signal level exceeds an upper or lower processing threshold level, or is distorted (e.g., clipped), the system applies a gain to the input signal level. The system may compensate for the gain in the output signal when the input signal includes desired signal content.
Owner:BLACKBERRY LTD

Guaranteed memory card performance to end-of-life

In order to maintain a memory system's performance levels to its end-of-life, latency threshold level(s) are specified and associated with different memory system operating parameters. In one embodiment, the memory system monitors and gathers performance statistics in real time, and in accordance with specific memory transfer sizes. A current latency level can be dynamically calculated using the performance statistics and compared to previously established latency threshold levels. If the current latency level is greater than or equal to a specific latency threshold level, the memory system's configuration setting can be adjusted according to the operating parameters associated with the latency threshold level to offset the increased latency.
Owner:SANDISK TECH LLC

Controlled release formulations using intelligent polymers

InactiveUS20080292700A1Prevent burstImparts gastrointestinal stealth characteristicNervous disorderMetabolism disorderSmart polymerTopiramate
A controlled release pharmaceutical composition comprises (a) topiramate or a pharmaceutically acceptable salt thereof, (b) a first intelligent polymer component; and (c) a second intelligent polymer component having opposite wettability characteristics to the first intelligent polymer component. The polymer components are effective for controlled release of the pharmaceutically active substance from the composition.
Owner:VALEANT INT BARBADOS

Pulsatile release compositions of milnacipran

InactiveUS20060003004A1Minimize exposureReduces milnacipran gastrointestinal side effectCapsule deliveryCoatingsPalpitationsPanic
A once-a-day oral milnacipran pulsatile release composition has been developed that releases the drug in spaced apart “pulses”. The dosage forms are comprised of first, second and optional third dosage units, with each dosage unit having a different drug release profile. This dosage form provides in vivo drug plasma levels characterized by Cmax below 3000 ng / ml, preferably below 2000 ng / ml, and most preferably below 1000 ng / ml. The composition provides pulsatile release of milnacipran to produce a therapeutic effect over approximately 24 hours, when administered to a patient in need, resulting in diminished incidence or decreased intensity of common milnacipran side effects such as sleep disturbance, nausea, vomiting, headache, tremulousness, anxiety, panic attacks, palpitations, urinary retention, orthostatic hypotension, diaphoresis, chest pain, rash, weight gain, back pain, constipation, vertigo, increased sweating, agitation, hot flushes, tremors, fatigue, somnolence, dyspepsia, dysoria, nervousness, dry mouth, abdominal pain, irritability, and insomnia.
Owner:COLLEGIUM PHARMA INC

System and methods for reducing particulate matter emissions

A method for a vehicle comprises responsive to installation of a new exhaust particulate filter, doping fuel with an ash-producing additive, and combusting the doped fuel to produce ash, wherein the ash deposits as an ash coating on the new exhaust particulate filter. In this way, a filtration efficiency of an exhaust particulate filter can be increased quickly as compared to a filter with no deposited ash coating, inexpensively as compared to conventional methods using membranes, and with a lower back pressure drop as compared to conventional methods.
Owner:FORD GLOBAL TECH LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products